FDA warns on false results for Thermo Fisher TaqPath COVID-19 testing kit

The FDA today issued a warning for labs and healthcare providers due to a risk of false results with a Thermo Fisher Scientific (NYSE:TMO) COVID-19 test kit.

Results from the Thermo Fisher TaqPath COVID-19 Combo Kit may be false, based on two issues related to the test kit and the associated Applied Biosystems COVID-19 interpretive software, according to an FDA release.